PPT-SUPPLEMENTAL FIGURE 1. Percentage of

children aged 25 years with employersponsored insurance receiving clinical care for attentiondeficithyperactivity disorder ADHD United States 2014 SUPPLEMENTAL FIGURE 2 Percentage of . No CoursesClass Percentage General Percentage OBC Percentage SC Percentage ST Percentage PWD Remarks 1 BA Ist year 88 and above in agg 85 and above in agg 85 and above in agg 85 an ( General ) Percentage ( OBC ) Percentage ( SC ) Percentage ( ST ) Percentage ( PWD ) 1B.A. Ist year91% and above in agg.90% and above in agg.89% and above in agg.89% and above in agg.89% and above in Linda Beebe. June 2, 2011. SSP June 2, 2011. SSP June 2, 2011. Collision of 2 Worlds. SSP June 2, 2011. Explosion of─. . Research. . Data. . Accrued Knowledge. Increased Requirements. A. Academic/Research Program. Extent of Lung Resection. No. of Subject. Event. Censored. Median Survival (95% CI). 60 mo Survival. Lobectomy. 1778. 616 (35%). 1162 (65%). NA (99.6, NA). 73.6% (71.4%, 75.6%). March 28, 2012. Nina Brown, MPH, CHES, Public Health Analyst, OQD. Michelle Bright, Public Health Analyst, OAM. U.S. Department of Health and Human Services. Health Resources and Services Administration. ( General ) Percentage ( OBC ) Percentage ( SC ) Percentage ( ST ) Percentage ( PWD ) 1B.A. (Prog.) Ist yearADMISSION CLOSEDADMISSION CLOSED2B.A. (Prog.) SECOND ADMISSION LIST Kirori Mal Col TAM (1µM). 72 hours. IL-1β levels. 48 hours. LPS (1µM). 0. A. NLRP3i (400μM. ). B. Supplemental Figure 4. Effect of the NLRP3 inflammasome inhibitor on IL‑1β production in bone marrow derived macrophages (BMDM) from genetically modified mice with constitutively active NLRP3.. ppendix IFuel Transport Memorandum411 CuMoExplorationProject Supplemental Environmental Assessment413 Supplemental Environmental AssessmentCuMoplorationProject 414 CuMoExplorationProject Supplemental fpkm. ). PD-L1 (. fpkm. ). CD8 (. fpkm. ). Iba1 (. fpkm. ). p. < 0.001. p. < 0.001. p. < 0.001. p. < 0.001. GM-CSF. GM-CSF. GM-CSF. GM-CSF. Supplemental Figure 1. Gene expression analysis in breast cancer cases from TCGA database. Gene expression levels of CD8, Iba1, PD-L1, and PD-L2 in breast cancer were compared between the cases with and without GM-CSF expression. The Mann-Whitney . GSE47460_GPL14550 . GSE47460_GPL6480 . Supplemental Figure 2. Megakaryocyte score. Platelet score. FVC. DLCO. A. B. Megakaryocyte score. Platelet score. FVC. DLCO. r = -0.09331, p = 0.5237. r = 0.07781, p = 0.6721. Viral infection. Inflammation response. -log10(. p. -value) -log10(. A.. B.. Supplemental Figure 3. Control. α-synuclein. Vehicle. Nicotine. A.. B.. C.. D.. No RNAi. SV2L1 KD. SV2L2 KD. Scale bar: 10nm. 9.5nm. 14.7nm. Average diameter:. A. B. Supplemental figure 2. ELISA using FT and GnH-FT as antigens. A. B. * P <0.05, ** P<0.01, *** P<0.001, and **** P<0.00001. **. *. *. drived. using the Houseman deconvolution method [47] while observed cell counts were obtained from patients on Day 1 of ICU admission. In both cases cell counts are not significantly different between septic and non-septic patients. CD8, CD8+ T cells; CD4, CD4+ T cells, NK, natural killer cells; .